(2025)
Lactic acid in the vaginal milieu modulates the Candida-host interaction.
Virulence 16(1),
2451165.
Publications
(2024)
Organ-on-chip models for infectious disease research.
Nat Microbiol 9(4),
891-904.
(Review)
(2024)
Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology.
Oxf Open Immunol 5(1),
iqae010.
(Review)
(2024)
Microbial adaptive pathogenicity strategies to the host inflammatory environment.
FEMS Microbiol Rev 49,
fuae032.
(Review)
(2024)
Alpha1-antitrypsin impacts innate host-pathogen interactions with Candida albicans by stimulating fungal filamentation.
Virulence 15(1),
2333367.
(2024)
Leveraging organ-on-chip models to investigate host-microbiota dynamics and targeted therapies for inflammatory bowel disease.
Adv Healthc Mater ,
e2402756.
(Review)
(2024)
Modeling of intravenous caspofungin administration using an intestine-on-chip reveals altered Candida albicans microcolonies and pathogenicity.
Biomaterials 307,
122525.
(2024)
Pathogenicity strategies of Candida species during interactions with epithelial cells.
In: Brakhage AA, Kniemeyer O, Zipfel PF (eds.) The Mycota - Human and Animal Relationships 3. 6, pp. 35-49. Springer, Cham.
ISBN: 978-3-031-64852. (Review)
(2024)
A synthetic peptide mimic kills Candida albicans and synergistically prevents infection.
Nat Commun 15(1),
6818.
(2024)
Hyphal-associated protein expression is crucial for Candida albicans-induced eicosanoid biosynthesis in immune cells.
Eur J Immunol 54(3),
e2350743.